MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses-Reference-Cited by-同舟云学术

MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses

Published:2009-04-30 Issue:12 Volume:30 Page:1477-1485
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Onuma Yoshinobu,Serruys Patrick,den Heijer Peter,Joesoef Kaiyum Sheik,Duckers Henricus,Regar Evelyn,Kukreja Neville,Tanimoto Shuzou,Garcia-Garcia Hector M.,van Beusekom Heleen,van der Giessen Willem,Nishide Takuji

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/30/12/1477/17889545/ehp127.pdf

Reference36 articles.

1. Coronary-artery stents;Serruys;N Engl J Med,2006

2. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk;Joner;J Am Coll Cardiol,2006

3. Pathological mechanisms of fatal late coronary stent thrombosis in humans;Farb;Circulation,2003

4. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization;Finn;Circulation,2007

5. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?;Virmani;Circulation,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Is the axiom of balloon angioplasty, “the more you gain the more you lose”, still true in the era of DCB with paclitaxel?;Cardiovascular Revascularization Medicine;2024-04

2. The Orsiro Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stent: A Review of Current Evidence;Cardiovascular Revascularization Medicine;2020-04

3. First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis;EuroIntervention;2017-04

4. Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned;EuroIntervention;2016-11

5. Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study;EuroIntervention;2015-12